| Original language | English |
|---|---|
| Pages (from-to) | 1015-1016 |
| Number of pages | 2 |
| Journal | Neuro-Oncology |
| Volume | 25 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jun 2023 |
Bibliographical note
Funding Information:There was no manuscript-targeted external funding. Outside of the submitted work, ABL was supported in part by The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital, the Hearst Foundations, and by NIH/NCI/NCATS grants P30CA013696 and UL1TR001873. Publication costs were paid by The Michael Weiner Glioblastoma Research Into Treatment Fund.
Funding Information:
There was no manuscript-targeted external funding. Outside of the submitted work, ABL was supported in part by The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital, the Hearst Foundations, and by NIH/NCI/NCATS grants P30CA013696 and UL1TR001873. Publication costs were paid by The Michael Weiner Glioblastoma Research Into Treatment Fund.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver